Recombinant SARS-CoV 3CL Protease, CF Summary
Product Specifications
Product Datasheets
Carrier Free
CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.
In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.
E-718
| Formulation | Supplied as a solution in HEPES, NaCl, DTT and EDTA. |
| Shipping | The product is shipped with dry ice or equivalent. Upon receipt, store it immediately at the temperature recommended below. |
| Stability & Storage: | Store the unopened product at -70 °C. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Do not use past expiration date. |
Scientific Data
View Larger
GC376 achieved 50% inhibition of 50 nM SARS-CoV Virus 3CL Protease (Catalog # E-718) at a concentration of 101-120 nM.
View Larger
1 μg and 2 μg of Recombinant SARS-CoV Virus 3CL Protease (Catalog # E-718) was resolved with SDS-PAGE under reducing conditions and visualized by colloidal Coomassie Blue staining, showing a band at 33 kDa.
Reconstitution Calculator
Background: 3CL Protease
The 3CL protease (aka 3CLpro, Mpro or "Main Protease) from the human SARS-CoV coronavirus (Severe Acute Respiratory Syndrome coronavirus) is a C30-type cysteine protease located within the non-structural proteins 3 (NS3) section of the viral polypeptide. 3CLpro activity is required to process the viral polyprotein into functional, mature subunits, and there are 11 or more sites of cleavage, many containing the sequence LQ[S/A/G]; the protease cleaves c-terminal to the glutamine amino acid. Along with the CoV Papain-Like Protease (catalog number E-610), 3CLpro presents an attractive target for therapeutic intervention of coronavirus infections. Because no human proteases with a similar cleavage specificity are known, inhibitors of 3CLpro are unlikely to cause mechanism-based toxicity.
Citations for Recombinant SARS-CoV 3CL Protease, CF
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
2
Citations: Showing 1 - 2
Filter your results:
Filter by:
-
Novel dithiocarbamates selectively inhibit 3CL protease of SARS-CoV-2 and other coronaviruses
Authors: L Brier, H Hassan, X Hanoulle, V Landry, D Moschidi, L Desmarets, Y Rouillé, J Dumont, A Herledan, S Warenghem, C Piveteau, P Carré, S Ikherbane, FX Cantrelle, E Dupré, J Dubuisson, S Belouzard, F Leroux, B Deprez, J Charton
European Journal of Medicinal Chemistry, 2023-02-06;250(0):115186.
Species: Human
Sample Types: Reference Standard
-
All-Trans Retinoic Acid Exhibits Antiviral Effect against SARS-CoV-2 by Inhibiting 3CLpro Activity
Authors: T Morita, K Miyakawa, SS Jeremiah, Y Yamaoka, M Sada, T Kuniyoshi, J Yang, H Kimura, A Ryo
Viruses, 2021-08-23;13(8):.
Species: Human
Sample Types: Protein
Applications: Bioassay
FAQs
-
Does the Recombinant SARS-CoV 3 CL Protease, CF (Catalog # E-718) contain any linkers or tags in the sequence?
Recombinant SARS-CoV 3 CL Protease, CF (Catalog # E-718) is an E. coli derived protein with amino acids Ser3241-Gln3546 that does not contain any linkers or tags in the sequence.
Reviews for Recombinant SARS-CoV 3CL Protease, CF
There are currently no reviews for this product. Be the first to review Recombinant SARS-CoV 3CL Protease, CF and earn rewards!
Have you used Recombinant SARS-CoV 3CL Protease, CF?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
